Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive–compulsive disorder

被引:2
作者
Dimitris Kontis
Vasileios Boulougouris
Vasiliki Maria Papakosta
Stamatina Kalogerakou
Socrates Papadopoulos
Cornelia Poulopoulou
George N. Papadimitriou
Eleftheria Tsaltas
机构
[1] Athens University Medical School,Experimental Psychology Laboratory, Department of Psychiatry, Eginition Hospital
[2] University of Cambridge,Department of Experimental Psychology and the Behavioural and Clinical Neuroscience Institute (BCNI)
[3] Psychiatric Hospital of Attica,Department of Neurology, Eginition Hospital
[4] Athens University Medical School,Department of Psychiatry, Eginition Hospital
[5] Athens University Medical School,undefined
来源
Psychopharmacology | 2008年 / 200卷
关键词
Obsessive–compulsive disorder (OCD); Animal model; Fluoxetine; mCPP; Quinpirole; Serotonin receptors; Dopamine receptors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:597 / 610
页数:13
相关论文
共 265 条
[21]  
Dai XY(1990)Quinpirole-induced behavioral sensitization is enhanced by prior scheduled exposure to sucrose: a multi-variable examination of locomotor activity Arch Gen Psychiatry 47 577-585
[22]  
King N(1990)Specificity of serotonin reuptake inhibitors in the treatment of obsessive–compulsive disorder. Comparison of fluvoxamine and desipramine J Clin Psychiatry 51 S36-S43
[23]  
Badri F(1995)Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? Biol Psychiatry 38 138-149
[24]  
Sasaki T(2000)-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation Arch Gen Psychiatry 57 76-82
[25]  
Buchanan JA(1991)Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive–compulsive and major depressive disorders Psychiatry Res 36 1-17
[26]  
Kennedy JL(1992)Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive–compulsive disorder Arch Gen Psychiatry 49 21-28
[27]  
Blier P(2002)Serotonergic function in obsessive–compulsive disorder. Behavioral and neuroendocrine responses to oral J Clin Psychiatry 63 20-29
[28]  
de Montigny C(1998)-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers J Neurosci 18 10045-10052
[29]  
Boulougouris V(2003)Refractory obsessive–compulsive disorder: state-of-the-art treatment Neuropsychopharmacology 28 77-85
[30]  
Dalley JW(1972)Neurotoxic lesions of the dorsomedial thalamus impair the acquisition but not the performance of delayed matching to place by rats: a deficit in shifting response rules Exp Neurol 36 362-377